240 related articles for article (PubMed ID: 2569398)
1. Comparison of the effects of intravenous and oral betaxolol on antegrade and retrograde conduction in patients with atrioventricular nodal reentrant and atrioventricular reentrant tachycardia.
Kühlkamp V; Ickrath O; Haasis R; Seipel L
Eur Heart J; 1989 Jun; 10(6):493-501. PubMed ID: 2569398
[TBL] [Abstract][Full Text] [Related]
2. [Electrophysiologic effects of betaxolol on conduction properties of the antegrade and retrograde pathway in patients with typical atrioventricular node reentry tachycardia following intravenous and oral administration].
Kühlkamp V; Ickrath O; Haasis R; Seipel L
Z Kardiol; 1988 Aug; 77(8):527-33. PubMed ID: 3176596
[TBL] [Abstract][Full Text] [Related]
3. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
Kühlkamp V; Ickrath O; Schmid F; Mayer F; Haasis R; Seipel L
Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia.
Musto B; D'Onofrio A; Cavallaro C; Musto A; Greco R
Am J Cardiol; 1988 Aug; 62(4):229-33. PubMed ID: 3135739
[TBL] [Abstract][Full Text] [Related]
5. Role of intravenous isoproterenol in the electrophysiologic induction of atrioventricular node reentrant tachycardia in patients with dual atrioventricular node pathways.
Huycke EC; Lai WT; Nguyen NX; Keung EC; Sung RJ
Am J Cardiol; 1989 Nov; 64(18):1131-7. PubMed ID: 2479251
[TBL] [Abstract][Full Text] [Related]
6. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
Gambhir DS; Bhargava M; Nair M; Arora R; Khalilullah M
Indian Heart J; 1996; 48(2):133-7. PubMed ID: 8682552
[TBL] [Abstract][Full Text] [Related]
7. AV nodal reentrant tachycardia using three different AV nodal pathways.
Kühlkamp V; Haasis R; Seipel L
Eur Heart J; 1990 Sep; 11(9):857-62. PubMed ID: 2226514
[TBL] [Abstract][Full Text] [Related]
8. [Electrophysiologic effects of penticainide in patients with supraventricular tachycardia].
Kühlkamp V; Mewis C; Mayer F; Seipel L
Z Kardiol; 1990 Oct; 79(10):725-31. PubMed ID: 2087860
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiology and long-term efficacy of pentisomide in patients with supraventricular tachycardia.
Kühlkamp V; Mewis C; Seipel L
Int J Cardiol; 1992 Jul; 36(1):69-79. PubMed ID: 1428255
[TBL] [Abstract][Full Text] [Related]
10. [Cibenzoline: electrophysiologic effects of a new class I anti-arrhythmia agents in supraventricular tachycardia].
Pfitzner P; Manz M; Schütz R; Lüderitz B
Z Kardiol; 1989 Oct; 78(10):654-60. PubMed ID: 2686252
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological effects of a new antiarrhythmic agent, nicainoprol, in humans.
Sen S; Rettig G; Ozbek C; Fröhlig G; Schieffer H; Bette L
J Cardiovasc Pharmacol; 1986; 8(1):144-50. PubMed ID: 2419677
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiologic effects and antiarrhythmic efficacy of recainam in patients with supraventricular tachycardia.
Tai YT; Campbell RW; McComb JM
J Cardiovasc Pharmacol; 1991 Feb; 17(2):310-5. PubMed ID: 1709237
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiologic effects and efficacy of cibenzoline in patients with supraventricular tachycardia.
Fujiki A; Mizumaki K; Tani M; Yoshida S; Sasayama S
J Cardiovasc Pharmacol; 1992 Sep; 20(3):375-9. PubMed ID: 1279281
[TBL] [Abstract][Full Text] [Related]
14. [Sotalol in supraventricular tachycardia. Electrophysiologic measurements in Wolff-Parkinson-White syndrome and AV node re-entry tachycardia].
Manz M; Kuhl AJ; Lüderitz B
Z Kardiol; 1985 Sep; 74(9):500-5. PubMed ID: 4060827
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiologic effects, clinical efficacy and safety of intravenous and oral nadolol in refractory supraventricular tachyarrhythmias.
Saksena S; Klein GJ; Kowey PR; Calvo RA; Boccadamo R; Brown JE; Sharma AD; Gadhoke A; Olukotun AY
Am J Cardiol; 1987 Feb; 59(4):307-12. PubMed ID: 3812280
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and electrophysiologic effects of encainide for atrioventricular nodal reentrant tachycardia.
Naccarelli GV; Jackman WM; Akhtar M; Rinkenberger RL; Friday KJ; Dougherty AH; Tchou P; Yeung-Lai-Wah JA
Am J Cardiol; 1988 Dec; 62(19):31L-36L. PubMed ID: 3144165
[TBL] [Abstract][Full Text] [Related]
17. The mechanisms of spontaneous termination of reentrant supraventricular tachycardias.
Chiale PA; Baranchuk A; González MD; Sánchez RA; Garro HA; Fernández PA; Avalos CQ; Enriquez A; Elizari MV
Int J Cardiol; 2015 Jul; 191():151-8. PubMed ID: 25965623
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia.
Manz M; Steinbeck G; Lüderitz B
Am J Cardiol; 1985 Oct; 56(10):593-7. PubMed ID: 4050693
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiological effects and clinical efficacy of propafenone in children with recurrent paroxysmal supraventricular tachycardia.
Musto B; D'Onofrio A; Cavallaro C; Musto A
Circulation; 1988 Oct; 78(4):863-9. PubMed ID: 3168194
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of intravenous magnesium on atrioventricular node conduction in supraventricular tachycardia.
Stiles MK; Sanders P; Disney P; Brooks A; John B; Lau DH; Shashidhar ; Wilson L; Mackenzie L; Young GD
Am J Cardiol; 2007 Oct; 100(8):1249-53. PubMed ID: 17920366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
